{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:33:17Z","timestamp":1779877997195,"version":"3.53.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T00:00:00Z","timestamp":1457913600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00259-016-3346-0","type":"journal-article","created":{"date-parts":[[2016,3,13]],"date-time":"2016-03-13T20:13:29Z","timestamp":1457900009000},"page":"1400-1406","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Intra-individual comparison of 68Ga-PSMA-11-PET\/CT and multi-parametric MR for imaging of primary prostate cancer"],"prefix":"10.1007","volume":"43","author":[{"given":"F. L.","family":"Giesel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sterzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. P.","family":"Schlemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Holland-Letz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Mier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Afshar-Oromieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Haberkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kratochwil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,14]]},"reference":[{"issue":"1","key":"3346_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/jmri.23689","volume":"37","author":"L Dickinson","year":"2013","unstructured":"Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, et al. Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? J Magn Reson Imaging. 2013;37(1):48\u201358. doi: 10.1002\/jmri.23689 .","journal-title":"J Magn Reson Imaging"},{"issue":"11","key":"3346_CR2","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.crad.2015.06.093","volume":"70","author":"T Barrett","year":"2015","unstructured":"Barrett T, Turkbey B, Choyke PL. PI-RADS version 2: what you need to know. Clin Radiol. 2015;70(11):1165\u201376. doi: 10.1016\/j.crad.2015.06.093 .","journal-title":"Clin Radiol"},{"issue":"5","key":"3346_CR3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.2967\/jnumed.115.154153","volume":"56","author":"M Eiber","year":"2015","unstructured":"Eiber M, Maurer T, Souvatzoglou M, Beer AJ, Ruffani A, Haller B, et al. Evaluation of hybrid 68Ga-PSMA ligand PET\/CT in 248 patients with biochemical recurrence after radical prostatectomy. J Nucl Med. 2015;56(5):668\u201374. doi: 10.2967\/jnumed.115.154153 .","journal-title":"J Nucl Med"},{"issue":"2","key":"3346_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00259-014-2949-6","volume":"42","author":"A Afshar-Oromieh","year":"2015","unstructured":"Afshar-Oromieh A, Avtzi E, Giesel FL, Holland-Letz T, Linhart HG, Eder M, et al. The diagnostic value of PET\/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2015;42(2):197\u2013209. doi: 10.1007\/s00259-014-2949-6 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3346_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3188-1","author":"F Sterzing","year":"2015","unstructured":"Sterzing F, Kratochwil C, Fiedler H, Katayama S, Habl G, Kopka K, et al. 68Ga-PSMA-11 PET\/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients. Eur J Nucl Med Mol Imaging. 2015. doi: 10.1007\/s00259-015-3188-1 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"3346_CR6","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1007\/s00259-015-3106-6","volume":"42","author":"FL Giesel","year":"2015","unstructured":"Giesel FL, Fiedler H, Stefanova M, Sterzing F, Rius M, Kopka K, et al. PSMA PET\/CT with Glu-urea-Lys-(Ahx)-[(68)Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2015;42(12):1794\u2013800. doi: 10.1007\/s00259-015-3106-6 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"3346_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00259-013-2525-5","volume":"41","author":"A Afshar-Oromieh","year":"2014","unstructured":"Afshar-Oromieh A, Zechmann CM, Malcher A, Eder M, Eisenhut M, Linhart HG, et al. Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET\/CT for the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2014;41(1):11\u201320. doi: 10.1007\/s00259-013-2525-5 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3346_CR8","doi-asserted-by":"crossref","unstructured":"Slawin KM, Tenke P, Joniau S, Ellis WJ, Alekseev BY, Buzog\u00e1ny I et al., A phase 2 study of 99m Tc-trofolastat chloride (MIP-1404) SPECT\/CT to identify and localize prostate cancer (PCa) in high-risk patients (pts) undergoing radical prostatectomy (RP) and extended pelvic lymph node (ePLN) dissection compared to histopathology: an interim analysis. J Clin Oncol. 2014;32(suppl; abstr e16003).","DOI":"10.1200\/jco.2014.32.15_suppl.e16003"},{"issue":"4","key":"3346_CR9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00066-014-0765-3","volume":"191","author":"YJ Kim","year":"2015","unstructured":"Kim YJ, Cho KH, Pyo HR, Lee KH, Moon SH, Kim TH, et al. Radical prostatectomy versus external beam radiotherapy for localized prostate cancer: comparison of treatment outcomes. Strahlenther Onkol. 2015;191(4):321\u20139.","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"3346_CR10","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/bc200279b","volume":"23","author":"M Eder","year":"2012","unstructured":"Eder M, Sch\u00e4fer M, Bauder-W\u00fcst U, Hull WE, W\u00e4ngler C, Mier W, et al. 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging. Bioconjug Chem. 2012;23(4):688\u201397.","journal-title":"Bioconjug Chem"},{"key":"3346_CR11","unstructured":"Garibaldi E, Delmastro E, Gabriele D, Bresciani S, Russo F, Di Dia A et al., Clinical and technical feasibility of ultra-boost irradiation in Dominant Intraprostatic Lesion by Tomotherapy: preliminary experience and revision of literature. Panminerva Med. 2015 Apr 29. [Epub ahead of print]."},{"key":"3346_CR12","doi-asserted-by":"crossref","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA; and the Grading Committee. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol. 2015 Oct 21.","DOI":"10.1097\/PAS.0000000000000530"},{"issue":"12","key":"3346_CR13","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1158\/1055-9965.EPI-13-0668","volume":"22","author":"JL Kasperzyk","year":"2013","unstructured":"Kasperzyk JL, Finn SP, Flavin R, Fiorentino M, Lis R, Hendrickson WK, et al. Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(12):2354\u201363. doi: 10.1158\/1055-9965.EPI-13-0668 .","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-016-3346-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3346-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T10:01:54Z","timestamp":1567677714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-016-3346-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,14]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["3346"],"URL":"https:\/\/doi.org\/10.1007\/s00259-016-3346-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,14]]}}}